CareDx, Inc (CDNA)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 31.15 |
| Open | 30.89 |
| Bid | 30.41 x 200 |
| Ask | 30.52 x 100 |
| Day's Range | 30.18 - 31.54 |
| 52 Week Range | 4.80 - 34.84 |
| Volume | |
| Avg. Volume | 911,396 |
| Market Cap | 1.605B |
| Beta (5Y Monthly) | 1.77 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.98 |
| Earnings Date | Nov 06, 2024 - Nov 11, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 32.71 |
ZacksEncompass Health Opens 9th Hospital in SC: More in the Pipeline?
This new facility is part of EHC's continued strategy to meet the rising demand for rehabilitative services.
ZacksCommunity Health's Arm Northwest Urgent Buys 10 Arizona Facilities
CYH expects the acquisition from Carbon Health to be completed in the fourth quarter of 2024.
Business WireCareDx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
BRISBANE, Calif., September 14, 2024--CareDx, Inc. (Nasdaq: CDNA)- The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers — today announced that, on September 12, 2024, CareDx granted an option to purchase 100,651 shares of CareDx’s common stock (the "Kennedy Inducement Option") and 70,101 restricted stock units (the "Kennedy In
© 2024 Yahoo. All rights reserved.